Brazil puts extra weight behind cord blood programmes, stem cell R&D:
This article was originally published in Clinica
The Brazilian cancer institute (INCA) has been given the go-ahead to expand the national umbilical cord and placental blood bank (BSCUP), in support of related healthcare and research programmes. The national economic and social development bank has approved a R$4.1m (US$1.8m) investment, which will enable BSCUP to increase its capacity from 3,000 to 10,000 units. The investment will be used to extend and improve facilities, in line with international processing and storage standards, the health ministry stated, to increase the activity of the national marrow transplantation centre (CEMO) and help establish the national blood banks network, Brasilcord. Brazil's stem cell research programmes will also benefit from these expansion plans, said the health ministry.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.